PnuVax

PnuVax is a biomanufacturing company founded in 2008 that specializes in contract development and manufacturing services for biopharmaceuticals and cellular agriculture. The company utilizes process intensification and modern technologies to streamline bioprocessing, aiming to make the production of food and drugs more sustainable and affordable. Their infrastructure supports a wide range of capabilities, including pilot-scale studies up to 70L, scale-up studies up to 200L, and large-scale bacterial and mammalian/viral cultures up to 3,500L and 2,500L, respectively. Additionally, the company offers sterile fill-finish services and maintains cGMP-capable suites to facilitate development from early-stage research through commercial production.

PnuVax provides these services to help clients address high costs and product shortages in the healthcare and life sciences sectors. Their expertise spans preventive products, protein therapeutics, and cellular therapies, while their facility in Montreal supports warehousing and 3PL capabilities. The company is actively accepting new clients and positions itself as a partner for both startups and established entities seeking to bring world-changing products to market. Beyond contract services, they also maintain an online store for cGMP lyophilized pneumococcal polysaccharide products, demonstrating their capacity to support diverse research and commercial requirements.